Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Elisa Mazzantini"'
Autor:
Edoardo Benedetti, Ginevra Traverso, Giulia Pucci, Riccardo Morganti, Emilia Bramanti, Piero Lippolis, Maria Chiara Susini, Elisa Mazzantini, Rachele Giubbolini, Fabrizio Mavilia, Enrico Capochiani, Emanuele Neri, Chiara Arena, Francesca Cerri, Luigi De Simone, Katia Valentini, Salvatore Massimo Stella, Vittorio Ricchiuto, Benedetto Bruno, Sara Galimberti
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionNeutropenic enterocolitis (NEC) is a life-threatening complication reported in patients with acute myeloid leukemia (AML) following chemotherapy (CHT). Intensive induction and consolidation CHT may damage intestinal mucosa leading to a NE
Externí odkaz:
https://doaj.org/article/150d9c55905040fbb17b9715b34e5e19
Autor:
Serena Salehzadeh, Francesca Guerrini, Umberto Pizzano, Susanna Grassi, Elena Ciabatti, Lorenzo Iovino, Gabriele Buda, Francesco Caracciolo, Edoardo Benedetti, Enrico Orciuolo, Matteo Pelosini, Giovanni Consani, Giovanni Carulli, Maria Rita Metelli, Francesca Martini, Francesco Mazziotta, Elisa Mazzantini, Pietro Rossi, Rita Tavarozzi, Federica Ricci, Mario Petrini, Sara Galimberti
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-15 (2019)
Abstract Background In addition to morphological and cytogenetic features, acute myeloid leukemias are characterized by mutations that can be used for target-therapy; also the minimal/measurable residual disease (MRD) could be an important prognostic
Externí odkaz:
https://doaj.org/article/b3ed2a20c6eb42cc835f2b6750f72efe
Autor:
Gabriele Buda, Francesca Guerrini, Sara Galimberti, Enrico Orciuolo, Simone Pacini, Elisa Mazzantini, Mario Petrini
Publikováno v:
Hematology Reports, Vol 9, Iss 4 (2017)
Human positive regulatory domain I binding factor 1 (PRDI-BF1 or BLIMP-1) is a transcription factor that acts as a master regulator and has crucial roles in the control of differentiation and in maintaining survival of plasma cells (PC). The PRDM1 ge
Externí odkaz:
https://doaj.org/article/597cf498665e41f0af4a00516a2edd85
Autor:
Fabrizio Mavilia, Francesco Ghio, Giulia Cervetti, Claudia Baratè, Gaspare Tandredi, Dimitri Dardanis, Elisa Mazzantini, Pietro Rossi, Paola Sammuri, Valentina Guerri, Clara Bono, Susanna Grassi, Edoardo Benedetti, Sara Galimberti
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:CLO23-053
Autor:
Fabrizio Mavilia, Francesco Ghio, Giulia Cervetti, Claudia Baratè, Gaspare Tancredi, Dimitri Dardanis, Elisa Mazzantini, Pietro Rossi, Paola Sammuri, Valentina Guerri, Clara Bono, Susanna Grassi, Edoardo Benedetti, Sara Galimberti
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S262
Autor:
Fabrizio Mavilia, Francesco Ghio, Giulia Cervetti, Claudia Baratè, Gaspare Tancredi, Dimitri Dardanis, Elisa Mazzantini, Pietro Rossi, Paola Sammuri, Valentina Guerri, Clara Bono, Susanna Grassi, Edoardo Benedetti, Sara Galimberti
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S141
Autor:
Enrico Orciuolo, Federica Ricci, Serena Salehzadeh, Sara Galimberti, Giovanni Consani, Francesco Caracciolo, Susanna Grassi, Edoardo Benedetti, Rita Tavarozzi, Elisa Mazzantini, Mario Petrini, Elena Ciabatti, Lorenzo Iovino, Francesca Martini, Gabriele Buda, Giovanni Carulli, Francesco Mazziotta, Umberto Pizzano, Maria Rita Metelli, Pietro Rossi, Francesca Guerrini, Matteo Pelosini
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-15 (2019)
Cancer Cell International
Cancer Cell International
Background In addition to morphological and cytogenetic features, acute myeloid leukemias are characterized by mutations that can be used for target-therapy; also the minimal/measurable residual disease (MRD) could be an important prognostic factor.
Autor:
Alessia Di Vita, Riccardo Puccetti, Cristiana Domenichini, Elisa Mazzantini, Enrico Orciuolo, Francesco Caracciolo, Pietro Rossi, Matteo Pelosini, Susanna Grassi, Sara Galimberti, Elena Ciabatti, Francesco Mazziotta, Francesca Guerrini, Maria Rita Metelli, Mario Petrini, Serena Salehzadeh
Publikováno v:
Cancers
Volume 12
Issue 7
Cancers, Vol 12, Iss 1738, p 1738 (2020)
Volume 12
Issue 7
Cancers, Vol 12, Iss 1738, p 1738 (2020)
Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) interfere with cellular metabolism contributing to oncogenesis. Mutations of IDH2 at R140 and R172 residues are observed in 20% of acute myeloid leukemias (AML), and the availability of the IDH2 inhibi
Autor:
Mario Petrini, Simone Pacini, Enrico Orciuolo, Francesca Guerrini, Sara Galimberti, Elisa Mazzantini, Gabriele Buda
Publikováno v:
Hematology Reports, Vol 9, Iss 4 (2017)
Hematology Reports
Hematology Reports
Human positive regulatory domain I binding factor 1 (PRDI-BF1 or BLIMP-1) is a transcription factor that acts as a master regulator and has crucial roles in the control of differentiation and in maintaining survival of plasma cells (PC). The PRDM1 ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61154626c4e9035e7a19c8281f933a20
http://hdl.handle.net/11568/943581
http://hdl.handle.net/11568/943581
Autor:
Paolo Tortora, Sandro Zangrossi, Elisa Mazzantini, Gianni Dehò, Marta Del Favero, Federica Briani
Publikováno v:
Journal of Biological Chemistry. 283:27355-27359
Polynucleotide phosphorylase (PNPase), an enzyme conserved in bacteria and eukaryotic organelles, processively catalyzes the phosphorolysis of RNA, releasing nucleotide diphosphates, and the reverse polymerization reaction. In Escherichia coli, both